𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease

✍ Scribed by Hiroshige Fujishiro; Roberta Frigerio; Melinda Burnett; Kevin J. Klos; Keith A. Josephs; Anthony DelleDonne; Joseph E. Parisi; J. Eric Ahlskog; Dennis W. Dickson


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
185 KB
Volume
23
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Attention has been drawn to cardiac sympathetic denervation in Parkinson's disease (PD) based on clinical studies using [123I] metaiodobenzylguanidine scintigraphy; however, the histologic correlates and time course of cardiac sympathetic denervation are poorly understood. To address these issues, we used tyrosine hydroxylase (TH) immunohistochemistry to detect cardiac sympathetic nerve fibers in the epicardium of 4 normal controls, 11 cases with incidental Lewy bodies (iLBs), and 14 cases of PD. Cardiac sympathetic innervation was significantly less in PD than in normal controls and cases with iLBs (P < 0.05). There was also a decrease in TH‐immunoreactive fibers in iLB cases compared to normal controls (P < 0.01). TH‐immunoreactive fibers correlated with the PD stage (r = −0.75, P < 0.001), as well as with Hoehn & Yahr clinical stage (r = −0.61, P < 0.001), and disease duration (r = −0.63, P < 0.001). Immunohistochemistry for α‐synuclein showed neurites in epicardium in PD and iLB cases, but not in normal controls. The density of α‐synuclein neurites correlated with Braak PD stage (r = 0.38, P < 0.05), Hoehn & Yahr clinical stage (r = 0.44, P < 0.05), and disease duration (r = 0.42, P < 0.05). This study demonstrates that cardiac sympathetic degeneration and α‐synuclein pathology is present in presymptomatic phase of PD, and that both increase with disease duration and severity. © 2008 Movement Disorder Society.


📜 SIMILAR VOLUMES


Cardiac sympathetic degeneration correla
✍ Mutsumi Iijima; Mikio Osawa; Mitsuru Momose; Tatsu Kobayakawa; Sachiko Saito; Ma 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

## Abstract Autonomic and olfactory dysfunctions are considered markers for preclinical diagnosis in Parkinson's disease (PD), because pathological changes in these systems can start before motor symptoms develop. We investigated whether cardiac sympathetic function and olfactory function are assoc

Myocardial sympathetic degeneration corr
✍ Jörg Spiegel; Dirk Hellwig; Georgios Farmakis; Wolfgang H. Jost; Samuel Samnick; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

## Abstract In idiopathic Parkinson's disease (PD), different clinical subtypes are distinguished due to predominant motor symptoms: a tremor‐dominant type (TDT), an akinetic rigid type (ART), and a mixed type (MT). We compared myocardial sympathetic innervation, measured by MIBG scintigraphy, in d

Clinical, neuropsychological, and morpho
✍ Valeria Isella; Paola Melzi; Marco Grimaldi; Simona Iurlaro; Roberto Piolti; Car 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB

## Abstract Apathy is a salient feature of various neuropsychiatric disorders, from depression to Alzheimer's disease. We formally assess its prevalence in idiopathic Parkinson's disease (PD) together with its clinical, neuropsychological, and morphometric correlates. Thirty patients with PD and 25

Subthreshold depression in patients with
✍ Uwe Ehrt; Kolbjørn Brønnick; Peter Paul De Deyn; Murat Emre; Sibel Tekin; Roger 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 1 views

## Abstract ## Background About 40% of the patients with Parkinson's disease (PD) have depressive symptoms, either major depression (MD) or subthreshold depression. Depression was found to be associated with age and age at onset of PD, female gender, more severe parkinsonism, in particular with le

Analysis of the relationship between mus
✍ Kazumasa Shindo; Eri Kaneko; Harue Watanabe; Tetsuhiko Sugimoto; Emiko Ohta; Ken 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 1 views

## Abstract To analyze the correlation between muscle sympathetic nerve activity (MSNA) and cardiac ^123^I‐metaiodobenzylguanidine (MIBG) uptake in patients with Parkinson's disease (PD), we measured both parameters in 14 PD patients who were 51 to 82 years of age (mean, 63.1 ± 8.7 years). The dura